ProPhase Labs (NASDAQ:PRPH) Stock Quotes, Forecast and News Summary

Q: What sector and industry does ProPhase Labs (PRPH) operate in?

ProPhase Labs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

ProPhase Labs Stock (NASDAQ: PRPH) stock price, news, charts, stock research, profile.

Open	$0.65
Close	$0.61
Volume / Avg.	319.20K / 167.33K
Day Range	$0.61 - $0.70
52 Wk Range	0.64 - 7.48
Market Cap	$14.58M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	26
Short Interest	0.7%
Days to Cover	1

Recent News

S&P 500 Tops 6,000; Sezzle Shares Spike Higher

Avi Kapoor

Dow Tops 44,000; US Consumer Sentiment Increases In November

Avi Kapoor

Why ProPhase Labs (PRPH) Stock Is Down 47% Today

ProPhase Labs shares are trading lower by 50% during Friday's session. The company announced a 4.17 million share offering at 72 cents per share, totaling $3 million.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.65
Close	$0.61
Volume / Avg.	319.20K / 167.33K
Day Range	$0.61 - $0.70
52 Wk Range	0.64 - 7.48
Market Cap	$14.58M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	26
Short Interest	0.7%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ProPhase Labs (PRPH) stock?

You can purchase shares of ProPhase Labs (NASDAQ:PRPH) through any online brokerage.

View our list of the best stock brokerages

Who are ProPhase Labs (PRPH) competitors?

Other companies in ProPhase Labs’s space includes: Cingulate (NASDAQ:CING), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Jaguar Health (NASDAQ:JAGX).

What is the forecast, or price target, for ProPhase Labs (PRPH) stock?

ProPhase Labs has a consensus price target of $11.00.

What is the current price for ProPhase Labs (PRPH)?

The stock price for ProPhase Labs (NASDAQ: PRPH) is $0.6105 last updated December 20, 2024 at 4:01 PM EST.

Does ProPhase Labs (PRPH) pay a dividend?

A quarterly cash dividend of 0.30 per share of Class A Common Stock. The quarterly cash dividend was payable on June 3, 2022 to stockholders of record on May 24, 2022.

When is ProPhase Labs (NASDAQ:PRPH) reporting earnings?

ProPhase Labs’s Q4 earnings are confirmed for Friday, March 14, 2025.

Is ProPhase Labs (PRPH) going to split?

There is no upcoming split for ProPhase Labs.

What sector and industry does ProPhase Labs (PRPH) operate in?

ProPhase Labs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

ProPhase Labs

ProPhase Labs (PRPH) Forecast